Zoetis (ZTS) : Mondays money flow points at investors jumping to buy the stock on the weakness of price. $26.73 million worth of transactions were on upticks, whereas, the downticks accounted for $11.65 million worth of transactions. The net money flow was a positive $15.08 million and the uptick to downtick ratio was 2.29. However, the block trades showed a clear dominance of the bulls with a very healthy ratio of 24.43 in their favor. The net money flow into the stock was $13.57 million. The value of block trades done on downticks was only $0.58 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $14.15 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. Zoetis (ZTS) was trading at $51.98, down $0.09 during day. The stock slid -0.17% over the previous days close. For the week, the stock recorded 1.74% over the previous weeks close.
Shares of Zoetis Inc. rose by 3.11% in the last five trading days and 5.43% for the last 4 weeks. Zoetis Inc. is up 12.23% in the last 3-month period. Year-to-Date the stock performance stands at 10.01%.
Zoetis (NYSE:ZTS): During Mondays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $52.16 and $52.08 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $52.48. The buying momentum continued till the end and the stock did not give up its gains. It closed at $52.38, notching a gain of 0.77% for the day. The total traded volume was 2,280,767 . The stock had closed at $51.98 on the previous day.
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company markets products across four regions: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle, swine, poultry, sheep and fish, and the companion animal species of dogs, cats and horses, and five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceutical products. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.